Buprenorphine Detoxification - BBDVI - 19

Completed · Phase 2

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this study is to examine the long-term efficacy of alternate-day dosing schedules in promoting treatment compliance in the absence of confounding behavioral contingencies.

Key facts

Study ID

NCT00000237

Run by

National Institute on Drug Abuse (NIDA)

People needed

0

Starts

1997-05-01

Last updated by the study team

2005-08-17

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Treatment Research Center — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.